14C-urea breath test in patients undergoing anti-tuberculosis therapy

World Journal of Gastroenterology

Volumn 11, Issue 11, 2005, Pages 1712-1714

  Mirbagheri, Sayed Amir ^a   Sohrabpour, Amir Ali ^b   Hasibi, Mehrdad ^a   Moghimi, Babak ^a   Mohamadnejad, Mehdi ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Helicobacter pylori; Tuberculosis; Urea breath test (UBT)

Indexed keywords

ANTIBIOTIC AGENT; BISMUTH; ETHAMBUTOL; ISONIAZID; PROTON PUMP INHIBITOR; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT; CARBON; DIAGNOSTIC AGENT; UREA;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CLINICAL ARTICLE; DATA ANALYSIS; DRUG USE; ENTERITIS; FEMALE; HELICOBACTER PYLORI; HUMAN; INFECTION CONTROL; LUNG TUBERCULOSIS; MALE; PEPTIC ULCER; TUBERCULOSIS; TUBERCULOUS MENINGITIS; TUBERCULOUS PERITONITIS; TUBERCULOUS SPONDYLITIS; UREA BREATH TEST; BREATH ANALYSIS; CLINICAL TRIAL; HELICOBACTER INFECTION; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; BREATH TESTS; CARBON RADIOISOTOPES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; TUBERCULOSIS, PULMONARY; UREA;

EID: 17144384013     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i11.1712     Document Type: Article

References (28)

1. Fennerty MB. Helicobacter pylori. Arch Intern Med 1994; 154: 721-727
2. O'Connor HJ. The role of Helicobacter pylori in peptic ulcer disease. Scand J Gastroenterol 1994; 201: 11-15
3. Yamada T. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994; 272 65-69
4. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A review. Gastroenterology 1996; 110: 1244-1252
5. Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ Jr, Saeed ZA, Malaty HM. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992; 116: 705-708
6. Soll AH. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. JAMA 1996; 275: 622-629
7. de Boer WA, Tytgat GN. Regular review: Treatment of Helicobacter pylori infection. BMJ 2000; 320: 31-34
8. Peterson WL, Graham DY. Helicobacter pylori In: Feldman M, Scharschmidt BF, Sleisenger MH eds. Gastrointestinal and liver disease: Pathophysiology, diagnosis, management. 6th ed. Philadelphia: WB Saunders Pub 1998: 604-619
9. Vaira D, Holton J, Menegatti M, Ricci C, Gatta L, Geminiani A, Migholi M. Review article: Invasive and non-invasive tests for Helicobacter pylori infection. Aliment Pharmacol Ther 2000; 14: 13-22
10. Atherton JC, Spiller RC. The urea breath test for Helicobacter pylori. Gut 1994; 35: 723-725
11. Laine L, Estrada R, Trujillo M, Knigge K, Fennerty MB. Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann Intern Med 1998; 129: 547-550
12. Chey WD, Woods M, Scheiman JM, Nostrant TT, DelValle J. Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism. Am J Gastroenterol 1997; 92 446-450
13. Chey WD, Spybrook M, Carpenter S, Nostrant TT, Elta GH, Scheiman JM. Prolonged effect of omeprazole on the 14C-urea breath test. Am J Gastroenterol 1996; 91: 89-92
14. Atherton JC. Non-endoscopic tests in the diagnosis of Helicobacter pylori infection. Aliment Pharmacol Ther 1997; 11: 11-20
15. Mitchell HM, Li YY, Hu PJ, Liu Q, Chen M, Du GG, Wang ZJ, Lee A, Hazell SL. Epidemiology of Helicobacter pylori in southern China: Identification of early childhood as the critical period for acquisition. J Infect Dis 1992; 166: 149-153
16. Woeltje KF, Kilo CM, Johnson K, Primack J, Fraser VJ. Tuberculin skin testing of hospitalized patients. Infect Control Hosp Epidemiol 1997; 18: 561-565
17. Holmboe AM, Nissen-Meyer S. Gastroduodenal ulcer and pulmonary tuberculosis. Nord Med 1957; 57: 575-578
18. Malaty HM, Nyren O. Epidemiology of Helicobacter pylori infection. Helicobacter 2003; 8: 8-12
19. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995; 9: 33-39
20. Webb PM, Knight T, Greaves S, Wilson A, Newell DG, Elder J, Forman D. Relation between infection with Helicobacter pylori and living conditions in childhood: Evidence for person to person transmission in early life. BMJ 1994; 308: 750-753
21. Cave DR. Transmission and epidemiology of Helicobacter pylori. Am J Med 1996; 100: 12S-17S
22. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282: 677-686
23. Brenciaglia MI, Fornara AM, Scaltrito MM, Braga PC, Dubini F. Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori. J Chemother 1996; 8: 52-54
24. Heep M, Beck D, Bayerdorffer E, Lehn N. Rifampin and rifabutin resistance mechanism in Helicobacter pylori. Antimicrob Agents Chemother 1999; 43: 1497-1499
25. Fujimura S, Kato S, Kawamura T, Watanabe A. In vitro activity of rifampicin against Helicobacter pylori isolated from children and adults. J Antimicrob Chemother 2002; 49: 541-543
26. Sanaka M, Kuyama Y, Yamanaka M, Iwasaki M. Decrease in serum concentrations of Helicobacter pylori IgG antibodies during antituberculosis therapy: The possible eradication by rifampicin and streptomycin. Am J Gastroenterol 1999; 94: 1983-1984
27. Perri F, Festa V, Clemente R, Villani MR, Quitadamo M, Caruso N, Bergoli ML, Andriulli A. Randomized study of two 'rescue' therapies for Helicobacter pylori-infected patients after failure of standard triple therapies. Am J Gastroenterol 2001; 96: 58-62
28. Berning SE, Peloquin CA. Antimycobacterial agents: Isoniazid In: Yu V, Merigan T, Barriere S eds. Antimicrobial therapy and vaccines. Baltimore: Williams and Wilkins 1999: 654-662